CL vs EL vs KVUE
161 measures in 16 categories, one definition each, computed from filings and market data.
CL60.5
Colgate-Palmolive Company
Consumer Defensive · Household & Personal Products
$94.11 +1.52%$75.0B mkt cap
Score DNA
EL53.7
The Estée Lauder Companies Inc.
Consumer Defensive · Household & Personal Products
$104.54 −2.48%$37.9B mkt cap
Score DNA
KVUE61.9
Kenvue Inc.
Consumer Defensive · Household & Personal Products
$18.91 +1.23%$36.3B mkt cap
Score DNA
Price, rebased to 100 three years ago
CL EL KVUE · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | CL | EL | KVUE |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 1 | 5 | 4 |
| Last Congress purchase | 2026-06-02 | 2026-07-02 | 2026-06-16 |
| 13F net change in holders | +67 | 0 | −2 |
| ETFs adding shares, 30d | 1,229 | 1,149 | 1,139 |
| ETFs trimming, 30d | 971 | 833 | 852 |
| Net ETF funds, 30d | +258 | +316 | +287 |
Valuation
16 measures| Measure | CL | EL | KVUE |
|---|---|---|---|
| P/E (TTM) | 36.8x
73rd
|
208.1x
100th
|
21.9x
27th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 3.08
71st
|
— | 0.39
14th
|
| Price / sales | 3.6x
84th
|
2.5x
74th
|
2.4x
63rd
|
| Price / book | 317.9x
100th
|
10.0x
84th
|
3.4x
47th
|
| Price / tangible book | — | — | — |
| Price / free cash flow | 19.4x
56th
|
28.8x
100th
|
17.2x
50th
|
| Price / operating cash flow | 16.8x
69th
|
21.4x
94th
|
15.6x
62nd
|
| Enterprise value | $81.5B
95th
|
$43.6B
84th
|
$43.7B
89th
|
| EV / sales | 3.9x
84th
|
2.9x
79th
|
2.8x
74th
|
| EV / EBITDA | 21.2x
69th
|
26.5x
75th
|
13.8x
38th
|
| EV / EBIT | 25.5x
50th
|
51.3x
79th
|
16.8x
29th
|
| EV / free cash flow | 21.1x
56th
|
33.1x
81st
|
20.6x
50th
|
| Earnings yield | 2.7%
58th
|
0.5%
42nd
|
4.6%
84th
|
| FCF yield | 5.1%
53rd
|
3.5%
16th
|
5.8%
58th
|
| Operating cash flow yield | 5.9%
42nd
|
4.7%
21st
|
6.4%
47th
|
| Graham number (per share) | $4.08
0th
|
$10.87
36th
|
$10.32
27th
|
Profitability (TTM)
12 measures| Measure | CL | EL | KVUE |
|---|---|---|---|
| Gross margin | 60.4%
68th
|
75.5%
100th
|
58.2%
58th
|
| EBITDA margin | 18.2%
74th
|
10.9%
47th
|
20.5%
95th
|
| Operating margin | 20.7%
89th
|
11.1%
58th
|
19.5%
84th
|
| EBIT margin | 15.2%
79th
|
5.7%
47th
|
16.9%
89th
|
| Net margin | 9.7%
74th
|
1.2%
42nd
|
10.8%
79th
|
| NOPAT margin | 15.2%
89th
|
3.9%
32nd
|
14.6%
84th
|
| FCF margin | 18.3%
100th
|
8.7%
53rd
|
13.7%
63rd
|
| Operating cash flow margin | 21.2%
95th
|
11.8%
53rd
|
15.1%
63rd
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.5%
74th
|
| SG&A / revenue | 39.3%
63rd
|
64.4%
84th
|
29.2%
47th
|
| Stock comp / revenue | 0.5%
28th
|
2.1%
83rd
|
0.4%
11th
|
| Effective tax rate | 26.5%
79th
|
64.8%
100th
|
25.4%
74th
|
Returns on capital
11 measures| Measure | CL | EL | KVUE |
|---|---|---|---|
| ROE (on average equity) | 434.3%
100th
|
4.7%
47th
|
15.6%
68th
|
| ROA | 11.9%
95th
|
0.9%
42nd
|
6.2%
63rd
|
| ROIC | 47.5%
89th
|
6.2%
37th
|
12.5%
58th
|
| ROCE | 30.0%
100th
|
6.3%
53rd
|
12.5%
68th
|
| Return on tangible assets | 18.7%
100th
|
4.3%
47th
|
9.6%
63rd
|
| Cash ROIC (OCF / invested capital) | 66.3%
94th
|
18.6%
65th
|
13.0%
47th
|
| Gross profitability (GP / assets) | 75.7%
100th
|
57.5%
79th
|
33.5%
37th
|
| ROIC, 3-yr average | 35.0%
100th
|
1.2%
29th
|
7.7%
47th
|
| ROIC, 5-yr average | — | 6.4%
43rd
|
— |
| ROE, 5-yr average | — | 8.7%
50th
|
— |
| Incremental ROIC | -77.2%
42nd
|
-392.5%
5th
|
-268.9%
16th
|
Growth
17 measures| Measure | CL | EL | KVUE |
|---|---|---|---|
| Revenue growth (TTM YoY) | 5.2%
79th
|
5.1%
74th
|
1.8%
47th
|
| Revenue growth (QoQ) | 0.7%
32nd
|
-2.3%
5th
|
1.2%
37th
|
| Revenue CAGR, 3 yr | 4.1%
67th
|
-1.8%
28th
|
56.6%
100th
|
| Revenue CAGR, 5 yr | 4.3%
60th
|
-1.5%
33rd
|
— |
| Gross profit CAGR, 3 yr | 6.2%
56th
|
0.0%
28th
|
59.1%
100th
|
| Operating income CAGR, 3 yr | 4.2%
58th
|
3.6%
42nd
|
62.4%
100th
|
| Net income growth (TTM YoY) | -30.0%
20th
|
— | 16.9%
90th
|
| Net income CAGR, 3 yr | 10.8%
60th
|
-43.4%
10th
|
56.8%
90th
|
| EPS growth (TTM YoY) | -29.0%
20th
|
— | 17.2%
80th
|
| EPS CAGR, 3 yr | 12.0%
60th
|
-43.7%
10th
|
56.6%
90th
|
| EPS CAGR, 5 yr | -4.7%
11th
|
-42.2%
0th
|
— |
| FCF growth (TTM YoY) | 14.5%
23rd
|
96.4%
85th
|
29.6%
62nd
|
| FCF CAGR, 3 yr | 17.9%
69th
|
— | 47.1%
92nd
|
| Operating cash flow CAGR, 3 yr | 12.9%
64th
|
0.8%
36th
|
46.3%
93rd
|
| Book value CAGR, 3 yr | — | -12.4%
24th
|
-1.6%
41st
|
| Dividend CAGR, 3 yr | 1.4%
67th
|
-6.7%
8th
|
-80.9%
0th
|
| Sustainable growth rate | 45.8%
100th
|
-8.5%
0th
|
15.5%
82nd
|
Margin history & stability
7 measures| Measure | CL | EL | KVUE |
|---|---|---|---|
| Gross margin, 3-yr average | 60.2%
74th
|
73.7%
100th
|
57.9%
68th
|
| Operating margin, 3-yr average | 21.7%
95th
|
4.9%
32nd
|
15.8%
74th
|
| Net margin, 3-yr average | 12.8%
95th
|
-1.4%
37th
|
9.1%
68th
|
| FCF margin, 3-yr average | 17.3%
95th
|
7.6%
53rd
|
12.0%
79th
|
| Revenue stability (0-1) | 0.97
95th
|
0.67
37th
|
0.59
32nd
|
| Earnings stability (0-1) | 0.01
5th
|
0.79
84th
|
0.93
100th
|
| Margin stability (0-1) | 0.97
79th
|
0.97
68th
|
0.98
89th
|
Liquidity (latest quarter)
7 measures| Measure | CL | EL | KVUE |
|---|---|---|---|
| Cash & short-term investments | $1.4B
89th
|
$3.5B
95th
|
$1.1B
84th
|
| Net cash (− = net debt) | −$6.5B
11th
|
−$5.7B
16th
|
−$7.4B
5th
|
| Working capital | $160.0M
42nd
|
$1.4B
100th
|
$32.0M
21st
|
| Current ratio | 1.03
26th
|
1.22
42nd
|
1.01
21st
|
| Quick ratio | 0.67
21st
|
0.90
53rd
|
0.71
42nd
|
| Cash ratio (cash + ST investments / current liabilities) | 0.22
42nd
|
0.56
63rd
|
0.19
32nd
|
| Defensive interval (days) | 145 days
5th
|
189 days
32nd
|
247 days
47th
|
Leverage & solvency (latest quarter)
13 measures| Measure | CL | EL | KVUE |
|---|---|---|---|
| Total debt | $7.9B
84th
|
$9.2B
95th
|
$8.5B
89th
|
| Debt / equity | 33.29
95th
|
2.43
84th
|
0.80
47th
|
| Net debt / equity | 27.49
95th
|
1.51
74th
|
0.70
53rd
|
| Debt / assets | 46.8%
79th
|
46.8%
74th
|
31.7%
37th
|
| Debt / capital | 97.1%
95th
|
70.8%
84th
|
44.6%
47th
|
| Debt / EBITDA | 2.05
19th
|
5.61
62nd
|
2.68
44th
|
| Net debt / EBITDA | 1.69
19th
|
3.49
56th
|
2.33
38th
|
| Interest coverage (EBIT / interest) | 12.5x
83rd
|
2.5x
44th
|
6.9x
56th
|
| Cash interest coverage | 17.5x
83rd
|
5.3x
44th
|
6.2x
50th
|
| Debt payback (years of OCF) | 1.8 yrs
19th
|
5.2 yrs
69th
|
3.6 yrs
56th
|
| Liabilities / assets | 96.6%
95th
|
80.7%
84th
|
60.5%
58th
|
| IS credit model rating | A+ | BB | BBB- |
| Implied credit spread (bps) | 125
16th
|
475
58th
|
350
53rd
|
Efficiency
11 measures| Measure | CL | EL | KVUE |
|---|---|---|---|
| Asset turnover | 1.23
95th
|
0.76
37th
|
0.57
11th
|
| Fixed asset turnover | 4.54
39th
|
3.04
11th
|
6.92
50th
|
| Inventory turnover | 3.9
58th
|
1.8
11th
|
3.7
53rd
|
| Receivables turnover | 11.3
74th
|
9.9
47th
|
6.4
21st
|
| Days sales outstanding | 32 days
26th
|
37 days
53rd
|
57 days
79th
|
| Days inventory outstanding | 94 days
42nd
|
202 days
89th
|
99 days
47th
|
| Days payables outstanding | 86 days
58th
|
152 days
95th
|
146 days
89th
|
| Cash conversion cycle (days) | 41 days
32nd
|
86 days
58th
|
10 days
21st
|
| Capex / revenue | 2.8%
53rd
|
3.0%
65th
|
1.4%
18th
|
| Capex / depreciation | 0.93
76th
|
0.57
41st
|
0.37
12th
|
| Operating expense ratio | 42.5%
56th
|
68.5%
83rd
|
40.5%
50th
|
Cash flow & earnings quality
7 measures| Measure | CL | EL | KVUE |
|---|---|---|---|
| Operating cash flow / net income | 2.19
73rd
|
9.74
100th
|
1.40
27th
|
| FCF / net income | 1.89
73rd
|
7.23
100th
|
1.28
36th
|
| FCF / operating cash flow | 86.6%
62nd
|
74.2%
38th
|
91.0%
81st
|
| Capex / operating cash flow | 13.4%
38th
|
25.8%
62nd
|
9.0%
19th
|
| Accruals ratio | -14.1%
5th
|
-8.0%
26th
|
-2.5%
89th
|
| Sloan accruals ratio | 1.7%
84th
|
-5.3%
26th
|
-1.5%
58th
|
| Earnings quality score (0-1) | 0.75
9th
|
0.75
9th
|
1.00
73rd
|
Scores & forensic checks
15 measures| Measure | CL | EL | KVUE |
|---|---|---|---|
| IS score | 61
79th
|
54
58th
|
62
84th
|
| IS profitability | 72
100th
|
29
37th
|
56
74th
|
| IS growth | 49
53rd
|
60
89th
|
53
74th
|
| IS value | 39
26th
|
36
11th
|
53
84th
|
| IS momentum | 58
47th
|
88
100th
|
81
89th
|
| IS risk (safety) | 100
84th
|
65
47th
|
50
32nd
|
| IS quality | 64
63rd
|
55
53rd
|
79
84th
|
| IS balance sheet | 46
53rd
|
37
37th
|
51
63rd
|
| IS earnings quality | 62
42nd
|
74
74th
|
76
79th
|
| IS cash flow | 72
84th
|
64
58th
|
70
74th
|
| Piotroski F-score (0-9) | 8
79th
|
7
63rd
|
8
79th
|
| Altman Z-score | 6.9
95th
|
2.9
53rd
|
2.3
37th
|
| Beneish M-score | −3.14
16th
|
−2.90
37th
|
−2.41
89th
|
| Ohlson O-score | −5.71
79th
|
−6.88
47th
|
−7.82
26th
|
| IS credit score | 77
84th
|
44
42nd
|
54
47th
|
Size (TTM)
8 measures| Measure | CL | EL | KVUE |
|---|---|---|---|
| Market cap | $75.0B
95th
|
$37.9B
89th
|
$36.3B
84th
|
| Revenue | $21.0B
95th
|
$15.0B
79th
|
$15.4B
84th
|
| EBITDA | $3.8B
95th
|
$1.6B
79th
|
$3.2B
89th
|
| Net income | $2.0B
95th
|
$182.0M
63rd
|
$1.7B
84th
|
| Free cash flow | $3.9B
95th
|
$1.3B
79th
|
$2.1B
84th
|
| Total assets | $16.8B
79th
|
$19.8B
89th
|
$26.7B
95th
|
| Shareholders' equity | $236.0M
21st
|
$3.8B
84th
|
$10.6B
95th
|
| Employees | 33,600
84th
|
41,800
95th
|
21,890
74th
|
Price performance
9 measures| Measure | CL | EL | KVUE |
|---|---|---|---|
| 1 day | +1.5% | −2.5% | +1.2% |
| 1 week | +6.6% | +6.6% | +6.8% |
| 1 month | +7.2% | +11.4% | +7.0% |
| 3 months | +2.3% | +25.0% | −0.6% |
| 6 months | +10.3% | +37.2% | +7.3% |
| Year to date | +21.8% | −1.8% | +10.4% |
| 1 year | +22.0% | +10.1% | +17.7% |
| 3 years, cumulative | +43.9% | −22.2% | +5.8% |
| 5 years, cumulative | +37.8% | −64.2% | — |
Technicals
4 measures| Measure | CL | EL | KVUE |
|---|---|---|---|
| RSI 14 | 73.1 | 63.8 | 68.2 |
| From 52-week high | −5.3% | −13.8% | −6.1% |
| From 52-week low | +26.2% | +57.9% | +36.6% |
| Beta | 0.32 | 1.27 | 0.45 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17